Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct
- 24 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 23 (15) , 1945-1954
Abstract
Objective: To design a vaccine construct containing various but conserved HIV-1-derived epitopes and generating broad CD8+ T cell responses. Methods: HLA-B7mα3 transgenic H-2KbDbKO transgenic mice were used to identify potential new HLA-B07.02-restricted HIV-1-derived epitopes. Immunological recognition of these epitopes was confirmed by IFN-γ ELISpot assays with PBMCs from HLA-B*0702+ HIV-1-infected individuals. For these peptides as well as others previously identified, the capacity to induce cross-reactive responses against their frequent allelic variants was evaluated in the mouse model. A set of epitopes inducing strong T cell responses against various and conserved regions of HIV-1 was selected. A DNA vaccine was designed to express them as a unique antigen with or without a three amino acid ARY extension flanking each epitope. The spectrum of CD8+ T responses generated by polyepitope constructs was tested in HLA-B7mα3 transgenic mice. Results: Five new epitopes were identified in accessory and regulatory HIV-1 proteins. Twelve HLA-B07.02-restricted epitopes were selected on the basis of their structural conservation and cross-reactive immunogenicity. The ARY N-terminal extension flanking each epitope markedly increases their affinity for TAP and the use of this flanking extension in polyepitope vaccine has a sizable advantage to induce CD8+ T cell cytotoxic responses in mice following DNA immunization. Conclusion: The HLA-B7mα3 mouse model allows to rapidly identify various HIV-1-derived epitopes of vaccine interest. Grouped in a polyepitope construct designed to increase their processing, this vaccine may be suitable for inducing multiple and relevant HIV-1-specific CTL responses in humans.Keywords
This publication has 52 references indexed in Scilit:
- Identification of immunogenic HLA-B7 “Achilles’ heel” epitopes within highly conserved regions of HIVVaccine, 2008
- Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnoverJournal of Experimental Medicine, 2007
- HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotypeProceedings of the National Academy of Sciences, 2007
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsJournal of Experimental Medicine, 2006
- Identification of Subdominant Cytotoxic T Lymphocyte Epitopes Encoded by Autologous HIV Type 1 Sequences, Using Dendritic Cell Stimulation and Computer-Driven AlgorithmAIDS Research and Human Retroviruses, 2000
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROLAnnual Review of Immunology, 1997
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Recognition of HLA-B27 and related antigen by a monoclonal antibodyHuman Immunology, 1982